Virtus ETF Advisers LLC Pliant Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 7,697 shares of PLRX stock, worth $95,673. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,697

Previous 7,563 1.77%

Holding current value

$95,673

Previous $81,000 6.17%

% of portfolio

0.04%

Previous 0.04%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.52 - $14.35 $1,409 - $1,922	134 Added 1.77%	7,697 $86,000
Q2 2024 Aug 14, 2024	BUY	$10.58 - $15.61 $25,349 - $37,401	2,396 Added 46.37%	7,563 $81,000
Q1 2024 May 15, 2024	SELL	$14.14 - $19.59 $5,005 - $6,934	-354 Reduced 6.41%	5,167 $76,000
Q4 2023 Feb 15, 2024	BUY	$12.85 - $19.15 $18,696 - $27,863	1,455 Added 35.78%	5,521 $99,000
Q3 2023 Nov 07, 2023	SELL	$14.58 - $20.15 $5,875 - $8,120	-403 Reduced 9.02%	4,066 $70,000
Q2 2023 Aug 14, 2023	SELL	$18.12 - $30.56 $14,677 - $24,753	-810 Reduced 15.34%	4,469 $80,000
Q1 2023 May 15, 2023	SELL	$18.73 - $36.26 $37,909 - $73,390	-2,024 Reduced 27.71%	5,279 $140,000
Q4 2022 Feb 14, 2023	BUY	$17.0 - $25.43 $124,151 - $185,715	7,303 New	7,303 $141,000
Q2 2022 Aug 12, 2022	SELL	$4.11 - $8.75 $42,020 - $89,460	-10,224 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.01 - $14.1 $4,227 - $8,502	-603 Reduced 5.57%	10,224 $72,000
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.26 $53,509 - $79,631	4,361 Added 67.45%	10,827 $146,000
Q3 2021 Nov 15, 2021	SELL	$16.48 - $28.98 $5,487 - $9,650	-333 Reduced 4.9%	6,466 $109,000
Q2 2021 Aug 10, 2021	SELL	$28.05 - $37.69 $116,435 - $156,451	-4,151 Reduced 37.91%	6,799 $198,000
Q1 2021 May 17, 2021	BUY	$24.52 - $40.23 $4,683 - $7,683	191 Added 1.78%	10,950 $431,000
Q4 2020 Feb 12, 2021	BUY	$19.89 - $32.99 $213,996 - $354,939	10,759 New	10,759 $244,000

Others Institutions Holding PLRX

# of Institutions

168

Shares Held

63.2M

Call Options Held

245K

Put Options Held

373K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $605M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Pliant Therapeutics, Inc. Transaction History